Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Regenerative Medicine
 More »

THIS KEYWORD IS SPONSORED BY:

  • Athersys Gets Up to $2.8M for Heart Attack Regen Med Program
    MultiStem cell therapy is a regenerative medicine product that, according to Athersys, can promote tissue repair and healing in different ways. In addition to cardiovascular ...
    8-6-2013
  • GEN Publisher & CEO Honored for Stem Cell Education
    utility of stem cells. Several of the company's journals intersect with regenerative medicine, contributing to the field's overall scholarship while advancing stem cell ...
    8-6-2013
  • New RNA-Based Method for Producing iPSCs
    The VEE-RF RNA-based approach has broad applicability, the authors said, for the generation of iPSCs for ultimate use in human stem cell therapies in regenerative medicine. "This ...
    8-1-2013
  • Do VSELs Hold Water?
    ... Stanford University School of Medicine's Irving L. Weissman, M.D., director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine, said, "We found that every ...
    7-31-2013
  • $70M Stem Cell Clinic Development Plan Approved in California
    The governing board of California's stem cell agency, the California Institute for Regenerative Medicine (CIRM), has approved a $70 million plan to create a new statewide network ...
    7-26-2013
  • Mesoblast Wins $3.9M in Australian Tax Credits Tied to Mesenchymal...
    Mesoblast specializes in allogeneic or "off-the-shelf" regenerative medicine products that focus on repair of damaged issues and modulation of inflammatory responses in conditions ...
    7-18-2013
  • Scientists Prod Stem Cells to Create Self-Organized Vascular...
    mice. The researchers note that this approach could have implications for regenerative medicine. "In demonstrating the ability to rebuild a microvascular bed in a clinically ...
    7-17-2013
  • Seeing the Light: Mature Photoreceptors Made from Stem Cells
    It has been a big month for regenerative medicine, with one group of researchers reporting on their generation of human induced pluripotent stem cell (iPSC)-derived liver buds , ...
    7-17-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    ... areas and innovative technologies including regenerative medicine and vaccines, speed up drug development, and ensure sufficient investment in late-stage clinical pipeline. ...
    7-11-2013
  • Nile Therapeutics to Acquire Capricor
    Therapeutics for an undisclosed price, in a deal that creates a publicly traded drug developer that focuses on preventing and treating heart disease through regenerative medicine. ...
    7-8-2013
  • Scientists Transplant Functional, Lab-Grown Human Liver into...
    With human iPSC liver buds, researchers make progress in moving regenerative medicine toward the clinic. In the pursuit of regenerative medicine, scientists have long touted the ...
    7-3-2013
  • Microbioreactor Analysis Module
    over 20 years, TAP has been the leader in the design and development of automated cell culture systems with applications in bioprocessing, drug discovery and regenerative medicine. ...
    7-1-2013
  • iPSCs: Analysis of U.S. Patent Landscape
    stem cells incur. [Paul Fleet/Fotolia] Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have promised to revolutionize regenerative medicine and therapies. ...
    7-1-2013
  • Top 20 Corporate Venture Funds
    ... vaccines, next-generation NBEs such as cancer immunotherapeutics, regenerative medicine, and new platforms for identifying targets and biomarkers Year established: 2010 ...
    6-14-2013
  • ReGen Med: Straight Out of Mythology
    While regenerative medicine has the potential to impact virtually every clinical area, its promises are particularly important for diseases that have therapeutic options that are ...
    6-11-2013
  • More »

    Journal Articles

  • BMP-2 plasmid DNA as a substitute for BMP-2 protein in bone tissue...
    Fiona Wegman, Yvonne van der Helm, F Cumhur Oner, Wouter Dhert, Jacqueline Alblas
    Tissue Engineering, Part A
    Tissue Engineering, Part A Bone regeneration is one of the focus points in the field of regenerative medicine. A well-known stimulus of bone formation is bone morphogenetic ...
  • Transportation Conditions for Prompt Use of Ex-vivo Expanded...
    Elena Veronesi, Alba Murgia, Anna Casselli, Giulia Grisendi, Maria Serena Piccinno, Valeria Rasini, Rosaria Giordano, Tiziana Monemurro, Philippe Bourin, Luc Sensebe, Markus Rojewski, Hubert Schrezenmeier, Pierre Layrolle, Maria-Pau Ginebra, Carmen Bunu Paniatescu, Enrique Barrena, Fabio Catani, Paulo Paolucci, Jorge Sans Burns, Massimo Dominici
    Tissue Engineering, Part C: Methods
    in vivo bone-formation. A successfully validated transportation protocol extends the applicability of fresh stem cells involving multicentric trials for regenerative medicine.
  • Osteogenic potential of BMP-2-releasing self-assembled membranes
    Eun Ji Chung, Karen B Chien, Brian A Aguado, Ramille N Shah
    Tissue Engineering, Part A
    The purpose of this study was to investigate the potential of incorporating charged growth factors such as BMP-2 within the membrane for regenerative medicine applications. ...
  • Mesenchymal Stem Cells Maintain Long-Term In Vitro Stemness During...
    Anna Otte, Vesna Bucan, Kerstin Reimers, Ralf Hass
    Tissue Engineering, Part C: Methods
    .../or tissue replacement after transplantation and their prolonged clinical use raises heavy debates not only in the fields of tissue engineering and regenerative medicine to date. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll